Media Room

Stefanie Kutschmann, Good Manufacturing Practice Officer, Frankfurt, Germany

First quarter 2024 results

First quarter 2024 results were reviewed by management during a conference call with the financial community on April 25th. The presentation was followed by a Q&A session.

14:30 - 16:00 CET (8:30am – 10am EST)

Press releases

June 1, 2024
Media Update: Sanofi update on Zantac litigation
May 31, 2024
Press Release: Sanofi launches 2024 global Employee Stock Purchase Plan
May 31, 2024
Press Release: Dupixent recommended for EU approval by the CHMP to treat patients with COPD

Contact our media team

You are a journalist and have a question about Sanofi, please contact the Global Media relations team. Please note the contact details are only for journalists.

For any other request, please call the switchboard: +33 1 53 77 40 00

Publications

Declaration of extra-financial performance 2023 (ESG Report)
Download PDF
Half Year 2023 Financial Report XBRL Package
Download PDF
Half Year 2023 Financial Report
Download PDF
First quarter 2023 results
Download PDF